Abbie Newton: How Better Data Can Reduce Platelet Wastage
Abbie Newton, Account Manager UK and Ireland at Terumo Blood and Cell Technologies, shared a post on LinkedIn about a recent article by Anna Lizoń et al., published in Vox Sanguinis, adding:
“Smarter platelet collection starts with better use of data.
An interesting study shared by International Society of Blood Transfusion (ISBT) and published in Vox Sanguinis highlights how improved platelet inventory management and collection planning helped a blood centre in Poland reduce platelet expiry rates from 1.86% to just 0.04%.
The key takeaway? It’s not just about collecting more platelets, but collecting the right components, in the right quantities, at the right time.
This is where connected technologies such as Terumo Blood and Cell Technologies Trima Accel and TOMEs can support blood services, providing valuable collection data to help optimise apheresis operations and align collection strategies with clinical demand.
A great example of how data-driven approaches can support more efficient blood component collection and ultimately benefit patients.”
Title: Optimization of platelet concentrate inventory management using a simple standardized decision-support model: A retrospective study from a Regional Blood Center
Authors: Anna Lizoń, Monika Marszałek, Wirginia Krzyściak
Stay updated with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian